finance.yahoo.com ·
Beaten Down Tempus AI Stock
Topic context
This topic has been covered 317329 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article discusses Tempus AI (TEM) stock performance and investor sentiment. No concrete commercial mechanism (e.g., revenue change, cost impact, supply disruption) is reported. The stock's volatility and sell rating reflect market perception but lack operational business impact details. Sector impact is weak and indirect.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Tempus AI stock rated 88% Strong Sell by Barchart.
- Stock lost approximately 26% year-to-date.
- 60-month beta of 3.99 (4x more volatile than S&P 500).
- Company developing AI operating system for healthcare (genomic testing, AI software, data monetization for pharma).
- Investor skepticism regarding differentiation and competition from hospitals and larger healthcare entities.
Related stories
fool.com
Canaan Can Q1 2026 Earnings Transcript
fool.com
Keysight Keys Q2 2026 Earnings Transcript
livemint.com
Haryana Bars Petrol Diesel Cabs for Aggregators What Means Pm Modis Austerity Push Ncrs Aqi Fuel News
finance.yahoo.com
Capsovision Q1 Earnings Call Highlights
fool.com